# Prelude Therapeutics Inc: Form 8-K, filed Sep 19, 2025

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2025-09-19
- Accepted by EDGAR: Sep 19, 2025, 07:41 ET
- Period: 2025-09-18
- Accession: 0001193125-25-208187
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000119312525208187/prld-20250918.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000119312525208187/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000119312525208187/prld-20250918.htm

Filed Sep 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-208187. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
